These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 8335918

  • 41. Transmission blocking vaccine studies in leishmaniasis: II. Effect of immunisation using Leishmania major derived 63 kilodalton glycoprotein, lipophosphoglycan and whole parasite antigens on the course of L. major infection in BALB/c mice.
    Tonui WK, Mbati PA, Anjili CO, Orago AS, Turco SJ, Githure JI, Koech DK.
    East Afr Med J; 2001 Feb; 78(2):90-2. PubMed ID: 11682953
    [Abstract] [Full Text] [Related]

  • 42. Nitric oxide production in murine leishmaniasis: correlation of progressive infection with increasing systemic synthesis of nitric oxide.
    Evans TG, Reed SS, Hibbs JB.
    Am J Trop Med Hyg; 1996 May; 54(5):486-9. PubMed ID: 8644903
    [Abstract] [Full Text] [Related]

  • 43. Experimental cutaneous leishmaniasis. II. A possible role for prostaglandins in exacerbation of disease in Leishmania major-infected BALB/c mice.
    Farrell JP, Kirkpatrick CE.
    J Immunol; 1987 Feb 01; 138(3):902-7. PubMed ID: 3100619
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. DNA damage and nitric oxide production in mice following infection with L. chagasi.
    de Oliveira LR, Cezário GA, de Lima CR, Nicolete VC, Peresi E, de Síbio MT, Picka MC, Calvi SA.
    Mutat Res; 2011 Aug 16; 723(2):177-81. PubMed ID: 21570479
    [Abstract] [Full Text] [Related]

  • 46. Induction of iron-derived EPR signals in murine cancers by nitric oxide. Evidence for multiple intracellular targets.
    Bastian NR, Yim CY, Hibbs JB, Samlowski WE.
    J Biol Chem; 1994 Feb 18; 269(7):5127-31. PubMed ID: 7508933
    [Abstract] [Full Text] [Related]

  • 47. The effect of BCG on experimental cutaneous leishmaniasis in mice.
    Weintraub J, Weinbaum FI.
    J Immunol; 1977 Jun 18; 118(6):2288-90. PubMed ID: 864260
    [Abstract] [Full Text] [Related]

  • 48. Nitric oxide production during murine Lyme disease: lack of involvement in host resistance or pathology.
    Seiler KP, Vavrin Z, Eichwald E, Hibbs JB, Weis JJ.
    Infect Immun; 1995 Oct 18; 63(10):3886-95. PubMed ID: 7558296
    [Abstract] [Full Text] [Related]

  • 49. Effects of nitric oxide (NO) synthesis inhibition on antitumor responses during interleukin-2 (IL-2) treatment of mice.
    Yim CY, Lee CW, Choi SM, Park SS, Lee SJ, Kim JH, Song JS, Yoo WH, Kwak JY, Sohn MH.
    Korean J Intern Med; 1996 Jun 18; 11(2):93-100. PubMed ID: 8854644
    [Abstract] [Full Text] [Related]

  • 50. Molecular mechanism of T-cell control of Chlamydia in mice: role of nitric oxide in vivo.
    Igietseme JU.
    Immunology; 1996 May 18; 88(1):1-5. PubMed ID: 8707333
    [Abstract] [Full Text] [Related]

  • 51. Leishmania mexicana in C3H mice: BCG and levamisole treatment of established infections.
    Grimaldi GF, Moriearty PL, Hoff R.
    Clin Exp Immunol; 1980 Aug 18; 41(2):237-42. PubMed ID: 7438553
    [Abstract] [Full Text] [Related]

  • 52. Effectiveness and toxicity of protracted nitric oxide synthesis inhibition during IL-2 treatment of mice.
    Samlowski WE, Yim CY, McGregor JR, Kwon OD, Gonzales S, Hibbs JB.
    J Immunother Emphasis Tumor Immunol; 1995 Oct 18; 18(3):166-78. PubMed ID: 8770772
    [Abstract] [Full Text] [Related]

  • 53. Antileishmanial activities of macrophages from C3H/HeN and C3H/HeJ mice treated with Mycobacterium bovis strain BCG.
    Pappas MG, Nacy CA.
    Cell Immunol; 1983 Sep 18; 80(2):217-22. PubMed ID: 6349826
    [Abstract] [Full Text] [Related]

  • 54. The macrophage-activating tetrapeptide tuftsin induces nitric oxide synthesis and stimulates murine macrophages to kill Leishmania parasites in vitro.
    Cillari E, Arcoleo F, Dieli M, D'Agostino R, Gromo G, Leoni F, Milano S.
    Infect Immun; 1994 Jun 18; 62(6):2649-52. PubMed ID: 8188392
    [Abstract] [Full Text] [Related]

  • 55. L-arginine metabolism and its impact on host immunity against Leishmania infection.
    Wanasen N, Soong L.
    Immunol Res; 2008 Jun 18; 41(1):15-25. PubMed ID: 18040886
    [Abstract] [Full Text] [Related]

  • 56. Ferroportin-encapsulated nanoparticles reduce infection and improve immunity in mice infected with Leishmania major.
    Rafiee A, Riazi-Rad F, Darabi H, Khaze V, Javadian S, Ajdary S, Bahrami F, Alimohammadian MH.
    Int J Pharm; 2014 May 15; 466(1-2):375-81. PubMed ID: 24657288
    [Abstract] [Full Text] [Related]

  • 57. Possible roles of nitric oxide and peroxynitrite in murine leishmaniasis.
    Augusto O, Linares E, Giorgio S.
    Braz J Med Biol Res; 1996 Jul 15; 29(7):853-62. PubMed ID: 9070374
    [Abstract] [Full Text] [Related]

  • 58. Susceptibility of inbred mice to Leishmania major infection: genetic analysis of macrophage activation and innate resistance to disease in individual progeny of P/J (susceptible) and C3H/HeN (resistant) mice.
    Fortier AH, Tong A, Nacy CA.
    Infect Immun; 1990 Dec 15; 58(12):4149-52. PubMed ID: 2254035
    [Abstract] [Full Text] [Related]

  • 59. Prophylactic immunization against experimental leishmaniasis: I. Protection induced in mice genetically vulnerable to fatal Leishmania tropica infection.
    Howard JG, Nicklin S, Hale C, Liew FY.
    J Immunol; 1982 Nov 15; 129(5):2206-12. PubMed ID: 7119442
    [No Abstract] [Full Text] [Related]

  • 60. Essential role of platelet-activating factor in control of Leishmania (Leishmania) amazonensis infection.
    Lonardoni MV, Russo M, Jancar S.
    Infect Immun; 2000 Nov 15; 68(11):6355-61. PubMed ID: 11035745
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.